Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Opella Healthcare Belgium NV/SA from Machelen (Brab.), company number BE0753785218, closed financial year 2025 with a result of € 1.1 million after tax. For that financial year Opella Healthcare Belgium NV/SA recorded revenue of € 36.2 million and equity of € 20.7 million. Compared with financial year 2023, the result moved from € 2.4 million to € 1.1 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 20.7 million
▼ 4% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.1 million
▼ 53% vs 2023
Profit after tax over the fiscal year.
€ 2,225
▼ 97% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2 million.
People and assets in 2025
39.1
▼ 6.4 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 8.9 million
▲ 26% vs 2023
€ 226,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9.5 million
▲ 21% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 115 days on average.
€ 2.1 million
▼ 35% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 6,524,761 | € 37,310,705 | € 38,334,882 | € 36,216,334 | ▼ 6% |
| Profit after taxes | € -11,783 | € 386,486 | € 2,358,285 | € 1,113,246 | ▼ 53% |
| Equity | € 18,736,542 | € 19,123,028 | € 21,481,313 | € 20,672,701 | ▼ 4% |
| Total debts | € 6,704,231 | € 11,812,242 | € 11,164,909 | € 11,631,864 | ▲ 4% |
| Cash | € 355,029 | € 61,181 | € 82,461 | € 2,225 | ▼ 97% |
| Retained profit | € 42,977 | € 429,463 | € 2,787,748 | € 1,979,136 | ▼ 29% |
| Balance sheet total | € 25,440,773 | € 30,935,270 | € 33,286,221 | € 32,304,565 | ▼ 3% |
| Employees (FTE) | 43.5 | 43.8 | 45.5 | 39.1 | ▼ 6.4 |
Key figures of Opella Healthcare Belgium NV/SA, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Opella Healthcare Belgium NV/SA?
What happened at Opella Healthcare Belgium NV/SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Christian BETANCOURT stepped down as director. NBB
- Gilles LAHURE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.1 million (▼ 53% vs 2023). Source: NBB ↗
- Christian BETANCOURT became a director. NBB
- Gilles LAHURE became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 11,783 loss in 2021 to € 1.1 million profit in 2025.
Paid € 1.2 million in corporate taxes since 2021.
Best year ever: 2023, with € 2.4 million profit.
Pays suppliers within 115 days on average.
A new publication or filing at Opella Healthcare Belgium NV/SA? We notify you, reason included.
Follow Opella Healthcare Belgium NV/SADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SANOFI BELGIUM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Opella Healthcare Belgium NV/SAThe shares are held by Opella Healthcare Participations (100%) and SANOFI BELGIUM (100%).
Directors
According to the 2025 annual accounts
Christian BETANCOURT
Director
since 2023 · until 2029
since 2023 · until 2029
Shareholders
Opella Healthcare Participations
100%
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Leonardo da Vincilaan 19
1831 Machelen (Brab.)
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →CHEVRON PHILLIPS CHEMICALS INTERNATIONAL
€ 1.5 billion revenue · 2025
CGI Belgium
€ 24.4 million revenue · 2025
STRYKER
€ 61.1 million revenue · 2025
TARGUS
€ 206,352 gross margin · 2025
ARCADIUS
€ 32,203 gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0753.785.218
- VAT number
- BE 0753.785.218
- Registered office
- Leonardo da Vincilaan 19, 1831 Machelen (Brab.)
- Names & denominations
- Opella Healthcare Belgium NV/SA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 September 2020
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van overige farmaceutische producten
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren